Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

GeneQuantum Adds Five ADC Candidates to its Collaboration with Aimed, a Korean Biotech

publication date: Jul 13, 2023

Suzhou GeneQuantum Healthcare expanded its collaboration with Aimed Bio, a South Korean biotech, adding five ADC candidates for unmet needs to the partnership. GeneQuantum contributes its site-specific conjugation and linker-payload expertise, while Aimed, a spin-out from Samsung Medical Center, focuses on discovering drugs for severe brain diseases, including neuro-oncology and neurodegenerative diseases. In April 2022, the two companies announced a collaboration to develop an FGFR3-targeting ADC, which has now shown efficacy in in vivo models of bladder cancer and glioblastoma. The companies did not disclose the targets or financial details of the new collaboration. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital